Diagnostics & imaging AI · Chest CT/X-ray AI
Riverain Technologies
Riverain Technologies builds FDA-cleared ClearRead AI for chest CT and X-ray to support detection of lung disease and more efficient thoracic reads.
Strong fit
- Hospitals and imaging centers focused on finding lung nodules and chest disease on CT and X-ray
- Programs that will track detection results and reading time after ClearRead goes live
- Buyers comparing FDA-cleared AI tools built for chest imaging
Weak fit
- Sites whose main need is triage across specialties for stroke or pulmonary embolism
- Buyers without enough chest CT or X-ray volume to justify the module
- Teams that only need faster scans, which is Subtle's focus
Bottom line
Riverain Technologies is worth using for imaging programs focused on detection in chest CT and X-ray. It suits radiologists who want FDA-cleared ClearRead tools in their usual viewer.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Riverain Technologies builds FDA-cleared ClearRead AI for chest CT and X-ray, which helps radiologists find lung disease earlier and read chest studies faster. Its main users are hospitals and imaging centers looking for lung nodules and chest disease, and the company has focused on chest imaging for a long time.
Its scope is narrower than Aidoc's multi-specialty platform and different from Subtle's focus on faster scans. Setup is a clinical AI project tied into PACS, and pricing is custom. Results depend on radiologist trust, how false positives are handled, and whether reads stay in the usual viewer.
Among the diagnostic imaging AI tools we review, Riverain scores alongside Studycast for specialty imaging AI. Aidoc and Avicenna suit CT triage across many findings, Subtle suits faster scans, and Koios suits ultrasound decision support.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Aidoc | 7.9 | 7.5 |
| ScreenPoint Medical | 7.9 | 7.6 |
| Harrison.ai | 7.7 | 7.5 |
| Qure.ai | 7.4 | 7.1 |
| Optellum | 7.4 | 7.0 |
| Riverain Technologies | 7.3 | 6.9 |
| Subtle Medical | 7.2 | 6.8 |
| DeepTek | 7.1 | 6.8 |
| AZmed | 6.9 | 6.7 |
| Enlitic | 6.9 | 6.5 |
| Avicenna.AI | 6.9 | 6.6 |
| Ferrum Health | 6.8 | 6.5 |
| Koios Medical | 6.7 | 6.3 |
Pricing
| Item | Detail |
|---|---|
| Model | Software licenses for ClearRead CT and X-ray modules, priced by site and volume. |
| What usually drives cost | Number of sites, scan types (CT or X-ray), volume, and setup (on-site or cloud). |
| What to ask before you buy | Cost at your chest CT and X-ray volume, which FDA-cleared uses are covered, and PACS integration scope. |
| Published pricing | No price list is posted, and each contract is quoted. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Riverain Technologies to function | |
| A clinical owner in radiology, plus imaging IT | Radiology decides how ClearRead is used, and imaging IT connects it to PACS. |
| A written plan for connecting to PACS, RIS, and the EMR | AI results need to appear where radiologists already read, or findings can be missed. |
| Agreement on which kinds of scans are covered | Starting with agreed scan types gets the first results live sooner. |
| A plan for who reviews alerts and AI-enhanced images | Someone has to check each flagged finding and AI-enhanced image. |
| Agreed times for changes that could interrupt clinical work | Changes made during busy reading hours disrupt radiologists and erode trust in the tool. |
| What will maximize your value | |
| Measure turnaround, reopened reports, or the detection numbers agreed at kickoff | These numbers show how ClearRead performs on your own cases. |
| Start with one common type of scan | One common scan type gives a clear early result before more are added. |
| Review false alarms with radiologists every week | Tools that raise too many false alarms get turned off. |
| Keep radiologists in the viewers they use now when possible | Radiologists use AI more when it does not add a separate reading list. |
| Check which of your scan types the FDA clearances cover | Paying for clearances that do not match your scans wastes money. |
| Deal-breakers | |
| There is no imaging IT or clinical owner. | |
| You will not do any connection work. | |
| You expect imaging AI to write clinical notes. | |
| No one will review alerts or AI-enhanced images. | |
| Your legal team blocks the cloud or vendor handling of patient data that you need. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Scope | 2-4 weeks. Agree on scan types, connections, and how success is measured. |
| 2 | Connect | 4-12 weeks. Connect to PACS, RIS, and the EMR, and test on real cases. |
| 3 | Pilot | 4-8 weeks. Run at one site or for one kind of scan. |
| 4 | Expand | Ongoing. Add sites and make adjustments. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.